Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Sees Significant Increase in Short Interest

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 22,000 shares, a growth of 185.7% from the March 31st total of 7,700 shares. Based on an average trading volume of 3,178,000 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, BNP Paribas upgraded shares of Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research report on Tuesday, January 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $6,996.67.

Reckitt Benckiser Group Price Performance

RBGLY traded up $0.10 during trading on Friday, reaching $11.10. 834,719 shares of the company’s stock were exchanged, compared to its average volume of 1,457,875. The company’s fifty day moving average price is $11.93 and its 200-day moving average price is $13.23. Reckitt Benckiser Group has a fifty-two week low of $10.24 and a fifty-two week high of $16.60.

Reckitt Benckiser Group Increases Dividend

The company also recently declared a dividend, which will be paid on Monday, June 3rd. Stockholders of record on Friday, April 12th will be issued a $0.2701 dividend. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.18. The ex-dividend date of this dividend is Thursday, April 11th.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.